Dalagon, Apple Grace P.
HRN: 16-94-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2022
CEFTRIAXONE 1G (VIAL)
06/23/2022
06/30/2022
IV
2gm
OD
PC TNTC
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes